Editor-in-Chief & Deputy Editor 2019-2021





Deputy Editor:



Sponsors & Partners

Acta Gastroenterologica Belgica is supported by grants from its major sponsors


Acta Gastroenterologica Belgica is supported by grants

from its major sponsors

Dr Falk Pharma







Acta Gastro-Enterologica Belgica is published in

partnership with the following national societies









Primary prevention of colorectal cancer

Price: €10,00

Introduction Colorectal adenocarcinoma is the second most common cancer in the industrialised countries. In Belgium, more than 6000 new cases are diagnosed every year, among whom more than 50% will die of the disease (1), despite constant progress in treatment modalities, including surgery, radiation therapy or chemotherapy. Colon cancers arise as a result of a series of pathologic and molecular changes, which transform the normal cell into a cancerous cell, with an adenomatous polyp as an intermediate step in most cases. Necropsy data reveal that adenomatous polyps are as frequent as 50 percent in the general population by the age of 70 (2). Substantial progress is expected from prevention, which is generally divided into primary and secondary prevention. Secondary prevention deals with early detection and screening, and polyp removal. Primary prevention consists in identifying modulating factors and providing populations with advises and recommendations, or interventions with chemoprevention. It is a wide and promising field, with considerable benefit to be expected. For example, a 1% decrease in cancer incidence in the USA (more than 100.000 new cases per year, more than 50.000 deaths).... [Product Details...]